{"id":"NCT01473420","sponsor":"Pfizer","briefTitle":"A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin","officialTitle":"A Therapeutic-equivalence Study Comparing The Efficacy And Safety Of Subcutaneous Epoetin Hospira And Epoetin Alfa (Amgen) In Patients With Chronic Renal Failure Requiring Hemodialysis And Receiving Epoetin Maintenance Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01-17","primaryCompletion":"2014-02-28","completion":"2014-02-28","firstPosted":"2011-11-17","resultsPosted":"2018-06-20","lastUpdate":"2018-08-09"},"enrollment":320,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Renal Failure","Chronic Kidney Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Epoetin Hospira","otherNames":[]},{"type":"BIOLOGICAL","name":"Epogen Amgen","otherNames":["Epoetin Alfa"]}],"arms":[{"label":"Epoetin Hospira","type":"EXPERIMENTAL"},{"label":"Epogen (Amgen)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to demonstrate therapeutic equivalence of subcutaneous (SC) Epoetin Hospira compared to SC Epogen (Amgen), based on maintenance of hemoglobin (Hb) levels and study drug dose requirements in patients treated for anemia associated with chronic renal failure and on hemodialysis.","primaryOutcome":{"measure":"Mean Weekly Hemoglobin Level From Week 30 to Week 34: Maintenance Period","timeFrame":"Week 30 up to Week 34","effectByArm":[{"arm":"Epoetin Hospira: Maintenance Period","deltaMin":10.17,"sd":0.821},{"arm":"Epogen: Maintenance Period","deltaMin":10.11,"sd":0.838}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":73,"countries":["United States"]},"refs":{"pmids":["36791280","32734207"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":80},"commonTop":["Nausea","Dizziness","Fall","Injection Site Pain","Pyrexia"]}}